The revenue stands at ₹4,516.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.23 per cent from ₹4,173.00 crore. This corresponds to a year-on-year *(YoY) growth of 2.25 per cent.
Operating Profit stands at ₹939.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 74.02 per cent from ₹540.10 crore. This corresponds to a year-on-year *(YoY) decline of 12.83 per cent.
PBDT stands at ₹760.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.03 per cent from ₹447.50 crore. This corresponds to a year-on-year *(YoY) decline of 17.57 per cent.
Profit Before Tax stands at ₹247.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.04 per cent from ₹-67.80 crore. This corresponds to a year-on-year *(YoY) decline of 49.16 per cent.
Net Profit stands at ₹198.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 483.40 per cent from ₹-51.80 crore. This represents a 56.77 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Biocon | -0.06% | -1.54% | 0.24% | 18.10% | 15.46% | 11.30% |
| Laurus Labs | 1.76% | 3.30% | 18.76% | 55.69% | 85.19% | 110.78% |
| Dr Reddy's Labs | 0.28% | 1.05% | -16.16% | -10.90% | -7.46% | -6.35% |
| Aurobindo Pharma | 0.47% | 1.86% | -0.91% | 14.80% | 30.34% | 44.77% |
| Alkem Lab | -1.07% | 1.81% | 2.78% | 7.43% | 1.90% | 17.27% |
| Glenmark Pharma. | 1.28% | 2.22% | -1.64% | -6.66% | 14.06% | 7.68% |
| Abbott India | 0.72% | -0.44% | 3.47% | 9.27% | 2.46% | -18.38% |
Chairperson : Kiran Mazumdar Shaw
Non-Exec & Non-Independent Dir : Ravi Mazumdar
Non-Exec & Non-Independent Dir : Eric Vivek Mazumdar
Lead Independent Director : Naina Lal Kidwai
Independent Non Exe. Director : Rekha Mehrotra Menon
Independent Non Exe. Director : NICHOLAS ROBERT HAGGAR
Independent Non Exe. Director : Atul Dhawan
Managing Director & CEO : Shreehas Pradeep Tambe
Company Sec. & Compli. Officer : RAJESH UMAKANT SHANOY